Shanghai - Delayed Quote CNY

Shanghai LongYun Cultural Creation & Technology Group Co., Ltd. (603729.SS)

14.99

+0.17

+(1.15%)

At close: April 30 at 3:00:02 PM GMT+8

Stock market today: Dow, S&P 500, Nasdaq futures slip after record streak with Fed, earnings in focus

A cool-down might be on the horizon as major index futures slip following a record-breaking run of gains for the S&P 500.

Yahoo Finance 13 minutes ago

YM=F

NQ=F

ES=F
Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

Warren Buffett outlined years ago what it would take to be the next CEO at Berkshire Hathaway.

Yahoo Finance 3 hours ago

BRK-B
onsemi Reports First Quarter 2025 Results

SCOTTSDALE, Ariz., May 05, 2025--onsemi (the "Company") (Nasdaq: ON) today announced its first quarter 2025 results with the following highlights:

Business Wire 11 minutes ago

ON
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025SELARSDI is approved for all indications matching the reference productSELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to seve

GlobeNewswire 22 minutes ago

TEVA

TEVJF

ALVO
5 Things to Know Before the Stock Market Opens Monday

News of the day for May 5, 2025

Investopedia 48 minutes ago

^GSPC

DIS

PLTR
Warren Buffett delivered more than a 5,000,000% return to investors. This guy is going to replace him

Those who have followed Berkshire Hathaway have long-anticipated that the day would come when legendary investor and CEO Warren Buffett called it quits.

CNN Business 50 minutes ago

BRK-B
TG Therapeutics: Q1 Earnings Snapshot

MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. TGTX) on Monday reported first-quarter earnings of $5.1 million. The Morrisville, New York-based company said it had net income of 3 cents per share.

Associated Press Finance 1 hour ago

TGTX
BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update

—Q1 2025 ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)— —Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million— —Company now expects to be profitable for full year 2025, a year ahead of schedule— —Company pays down $75 million of debt; saves approximately $23.5 million over life of loan— —NDA submitted for ORLADEYO oral granules for children with HAE aged 2-11— —U.S. IND open for BCX17725 for Netherton syndrome— RESEARCH TRIANGLE PARK, N.C., May 05, 2025

GlobeNewswire 1 hour ago

BCRX
Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

Pershing Square to Support HHH’s Strategic Expansion Through Investment, Advisory, and Other Resources HHH Will Operate as a Diversified Holding Company Seeking to Acquire Controlling Interests in High-Quality, Durable Growth Public and Private Companies Howard Hughes Corporation, HHH’s Real Estate Development Business and Principal Subsidiary, Will Continue as the Nation’s Leading Community Builder Pershing Square’s Primary Purchase of HHH Stock for $100.00 per Share Represents a 48% Premium to

GlobeNewswire 1 hour ago

HHH
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

First quarter 2025 BRIUMVI U.S. net revenue of $119.7 million Raises full year 2025 global net revenue target to approximately $575 million and raises full year BRIUMVI U.S. net revenue target to approximately $560 million Conference call to be held today, Monday, May 5, 2025, at 8:30 AM ET NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent company

GlobeNewswire 1 hour ago

TGTX
These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, and More

Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, Microsoft kicks off Monday as the largest U.S. company by market cap, Netflix falls as President Donald Trump says he authorized a 100% tariff on films produced overseas. Palantir Technologies, meanwhile, is scheduled to report quarterly earnings Monday.

Barrons.com 1 hour ago

PLTR

AAPL

MSFT
Berkshire Hathaway Inc. News Release

OMAHA, Neb., May 05, 2025--(BRK.A; BRK.B) –

Business Wire 1 hour ago

BRK-B
Netflix, Disney, Paramount Stocks Fall. Blame Trump’s Movie Tariff Idea.

President Donald Trump took aim at the movie industry over the weekend, saying he will impose a 100% import tax on movies produced abroad. “I am authorizing the Department of Commerce, and the United States Trade Representative, to immediately begin the process of instituting a 100% Tariff on any and all Movies coming into our Country that are produced in Foreign Lands,” Trump wrote in a post on Truth Social. Netflix shares fell 4% to $1,109.76 in premarket trading Monday following the announcement.

Barrons.com 1 hour ago

NFLX
Buffett Bows Out at a Period of Peak Uncertainty for Markets

Trump wants a rate cut, Berkshire Hathaway without Warren Buffett, Barron’s Big Money survey, and more news to start your day.

Barrons.com 1 hour ago

DIS

NVDA

TSLA
Trending tickers: Berkshire Hathaway, Palantir, Shell, Netflix

The latest investor updates on stocks that are trending on Monday.

Yahoo Finance UK 1 hour ago

BRK-B

GBPEUR=X

GBP=X
Trump Vows 100% Tariffs on Foreign-Made Films

US President Donald Trump said Sunday that he plans to impose a 100% tariff on movies made outside o

PREMIUM
MT Newswires 1 hour ago

NFLX
Recursion Pharmaceuticals: Q1 Earnings Snapshot

SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. RXRX) on Monday reported a loss of $202.5 million in its first quarter. On a per-share basis, the Salt Lake City-based company said it had a loss of 50 cents.

Associated Press Finance 2 hours ago

RXRX
Gold Rises After Weekly Loss Before Fed Rate Decision This Week

(Bloomberg) -- Gold advanced — after its first back-to-back weekly loss this year — as investors mulled an uncertain outlook for global trade and the US economy ahead of a Federal Reserve rate decision this week.Most Read from BloombergThe Battle Over the Fate of Detroit’s Renaissance CenterNYC Real Estate Industry Asks Judge to Block New Broker Fee LawNJ Transit Strike Would Be ‘Disaster’ for Region, Sherrill SaysNJ Transit Urges Commuters to Work Remotely If Union StrikesIceland Plans for a Mo

Bloomberg 2 hours ago

GC=F
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 clinical programs and 1 preclinical program following a strategic, data-driven reviewPartnerships: Achieved fourth milestone in Sanofi collaboration, generating $7 million for an orally active small-molecule lead with best-in-class potential in autoimmune diseasesPlatform and Operations: Implemented

GlobeNewswire 2 hours ago

RXRX
As Buffett Steps Down, Omaha Is Grateful—and a Little Worried

Despite the billionaire’s frugal ways, his presence pumped up the local economy, drawing tourists and packing annual conventions.

The Wall Street Journal 2 hours ago

BRK-B

Performance Overview

Return	603729.SS	SSE Composite Index (000001.SS)
YTD	+2.11%	-2.17%
1-Year	-20.81%	+5.61%
3-Year	+25.97%	+7.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Shanghai LongYun Cultural Creation & Technology Group Co., Ltd. (603729.SS)

Related News

Stock market today: Dow, S&P 500, Nasdaq futures slip after record streak with Fed, earnings in focus

Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

onsemi Reports First Quarter 2025 Results

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

5 Things to Know Before the Stock Market Opens Monday

Warren Buffett delivered more than a 5,000,000% return to investors. This guy is going to replace him

TG Therapeutics: Q1 Earnings Snapshot

BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update

Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, and More

Berkshire Hathaway Inc. News Release

Netflix, Disney, Paramount Stocks Fall. Blame Trump’s Movie Tariff Idea.

Buffett Bows Out at a Period of Peak Uncertainty for Markets

Trending tickers: Berkshire Hathaway, Palantir, Shell, Netflix

Trump Vows 100% Tariffs on Foreign-Made Films

Recursion Pharmaceuticals: Q1 Earnings Snapshot

Gold Rises After Weekly Loss Before Fed Rate Decision This Week

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

As Buffett Steps Down, Omaha Is Grateful—and a Little Worried

Performance Overview